Apical and basolateral ATP-induced anion secretion in polarized human airway epithelia

Am J Respir Cell Mol Biol. 2004 Mar;30(3):411-9. doi: 10.1165/rcmb.2003-0183OC. Epub 2003 Sep 11.

Abstract

The present study investigated mechanisms underlying apical and basolateral P2Y(1)-mediated Cl(-) secretion in human airway epithelial cells. Apical and basolateral ATP induced short-circuit currents (I(sc)) with different properties via P2Y(1) receptors. The former comprised an immediate rise followed by a slow attenuation, whereas the latter was a transient rise with a higher peak and shorter duration (< 2 min). The actions of ATP were simulated by those of ADP, ADPbetaS, and ATPgammaS. Antagonists of phosphatidylinositol-phospholipase C (U73122, ET-18-OCH(3)) were without any effect on the bilateral ATP-induced I(sc), which were, in contrast, attenuated by a phosphatidylcholine-phospholipase C inhibitor (D609) and an adenylate cyclase inhibitor (SQ22536). The responses to ATP from either aspect were also sensitive to an intracellular Ca(2+) chelator, 1,2-bis (o-amino-phenoxy)-ethane-N,N,N',N'-tetraacetic acid tetra-(acetoxymethyl)-ester, or a Ca(2+)-activated K(+) channel inhibitor, charybdotoxin, although differential Ca(2+) signals were concomitant with each reaction. Nystatin permeabilization studies revealed a good correlation between the I(sc) and the basolateral K(+) current rather than the apical Cl(-) current under ATP-stimulated conditions. In conclusion, apical and basolateral P2Y(1) receptors couple with both phosphatidylcholine-phospholipase C and adenylate cyclase, leading to Cl(-) secretion, whose rate is essentially regulated by the Ca(2+)-activated K(+) channel-mediated K(+) conductance. This suggests the importance of this channel in airway mucociliary clearance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / analogs & derivatives*
  • Adenine / pharmacology
  • Adenosine Triphosphate / pharmacology*
  • Adenylyl Cyclase Inhibitors
  • Bridged-Ring Compounds / pharmacology
  • Calcium / metabolism*
  • Cell Polarity*
  • Charybdotoxin / pharmacology
  • Chloride Channels
  • Chlorides / metabolism*
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Electrophysiology
  • Enzyme Inhibitors / pharmacology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism*
  • Humans
  • Lung / drug effects
  • Lung / metabolism
  • Norbornanes
  • Phosphatidylcholines / metabolism
  • Phosphatidylinositols / metabolism
  • Phospholipid Ethers / pharmacology
  • Potassium / metabolism
  • Potassium Channels, Calcium-Activated / antagonists & inhibitors
  • Receptors, Purinergic P2 / metabolism
  • Receptors, Purinergic P2Y1
  • Thiocarbamates
  • Thiones / pharmacology
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Adenylyl Cyclase Inhibitors
  • Bridged-Ring Compounds
  • CFTR protein, human
  • Chloride Channels
  • Chlorides
  • Enzyme Inhibitors
  • Norbornanes
  • P2RY1 protein, human
  • Phosphatidylcholines
  • Phosphatidylinositols
  • Phospholipid Ethers
  • Potassium Channels, Calcium-Activated
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y1
  • Thiocarbamates
  • Thiones
  • Charybdotoxin
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • 9-(tetrahydro-2-furyl)-adenine
  • edelfosine
  • tricyclodecane-9-yl-xanthogenate
  • Adenosine Triphosphate
  • Type C Phospholipases
  • Adenine
  • Potassium
  • Calcium